Health Care Biocept Inc. (BIOC) Q2 2020 Earnings Call Transcript 5 years ago Biocept Inc. (NASDAQ: BIOC) Q2 2020 earnings call dated Aug. 12, 2020 Corporate Participants: Jody Cain -- Investor Relations Michael W. Nall -- President… Biocept (BIOC) revenue drops 23% in Q2; loss narrows 5 years ago Biocept (NASDAQ: BIOC) reported a narrower loss in the second quarter of 2020. The company's revenue declined by 23% year-over-year… Infographic: How SmileDirectClub (SDC) performed in Q2 2020 5 years ago SmileDirectClub Inc. (NASDAQ: SDC) reported second quarter 2020 earnings results today. Total revenue was $107 million compared to $195 million… Lemonade Inc. (LMND) Q2 2020 Earnings Call Transcript 5 years ago Lemonade Inc. (NYSE: LMND) Q2 2020 earnings call dated Aug. 12, 2020 Corporate Participants: Yael Wissner-Levy -- Vice President, Communications Daniel Schreiber -- Co-Founder,… Novavax (NVAX) stock tumbles despite beating bottom line estimates in Q2 5 years ago After Novavax (NASDAQ: NVAX) reported its progress on developing the COVID-19 vaccine at the end of February, the shares of… Aurinia Pharmaceuticals Inc. (AUPH) Q2 2020 Earnings Call Transcript 5 years ago Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) Q2 2020 earnings call dated Aug. 11, 2020 Corporate Participants: Glenn Schulman -- Senior Vice President, Corporate… 10x Genomics, Inc. (TXG) Q2 2020 Earnings Call Transcript 5 years ago 10x Genomics, Inc. (NASDAQ: TXG) Q2 2020 earnings call dated Aug. 11, 2020 Corporate Participants: Eric Jaschke -- Director of Investor Relations… Inovio (INO) aims to produce 100 million doses of COVID-19 vaccine in 2021 5 years ago Shares of INOVIO (NASDAQ: INO) were down over 23% on Tuesday, a day after the company reported second quarter 2020… Trxade launches integrated COVID-19 risk assessment tool for corporate clients 5 years ago Integrated drug procurement firm Trxade Group (NASDAQ: MEDS) on Tuesday launched a one-of-its-kind platform that brings together various services such… Sage Therapeutics Inc (SAGE) Q2 2020 Earnings Call Transcript 5 years ago Sage Therapeutics Inc (NASDAQ: SAGE) Q2 2020 earnings call dated August 10, 2020 Corporate Participants: Jeff Boyle -- Senior Director of Investor… Next» « Previous